Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Trial record 1 of 2 for:    Empty Sella Syndrome
Previous Study | Return to List | Next Study

Growth Hormone Deficiency and Empty Sella Cardio-Metabolic Risk Factors in Obesity: a Cross-Sectional Study

This study has been completed.
Information provided by (Responsible Party):
Lucio Gnessi, University of Roma La Sapienza Identifier:
First received: March 17, 2014
Last updated: March 18, 2014
Last verified: March 2014
Obesity is a disease not always attributable to nutritional imbalance, frequently associated with changes in key hypothalamic-pituitary (HP) axes. The regain of weight loss after hypochaloric diets has been ascribed to these HP disregulations. The aim of the study is to explore pituitary morphology and its association with pituitary function and metabolic phenotype in outpatient obese individuals evaluated in the period 2010-2013 at the Department of Experimental Medicine of the University of Rome La Sapienza, with features of HP disease in a cross-sectional .


Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Cross-Sectional
Official Title: Growth Hormone Deficiency, Empty Sella and Cardio-Metabolic Risk Factors in Obesity: a Cross-Sectional Study.

Resource links provided by NLM:

Further study details as provided by University of Roma La Sapienza:

Primary Outcome Measures:
  • Cranio-caudal pituitary diameter in millimeters [ Time Frame: Participants will be followed for the duration of day hospital stay, an expected average of 1 week ]

Secondary Outcome Measures:
  • Growth hormone releasing hormone plus arginine test for GH secretion μg/L [ Time Frame: Participants will be followed for the duration of day hospital stay, an expected average of 1 week ]

Enrollment: 447
Study Start Date: March 2007
Study Completion Date: March 2014
Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Obese patients, no treatment


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Inclusion Criteria:

  • Adult obese

Exclusion Criteria:

  • psychiatric disturbances, pregnancy, lactation, or drugs known to affect pituitary function
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT02092779

Sponsors and Collaborators
University of Roma La Sapienza
Principal Investigator: Lucio Gnessi, MD, PhD University of Roma La Sapienza
  More Information

Responsible Party: Lucio Gnessi, Associate Professor, University of Roma La Sapienza Identifier: NCT02092779     History of Changes
Other Study ID Numbers: GHD2014
Dept.Exp.Med.Sapienza.Rome ( Other Identifier: Sapienza University of Rome )
Study First Received: March 17, 2014
Last Updated: March 18, 2014

Additional relevant MeSH terms:
Dwarfism, Pituitary
Nutrition Disorders
Body Weight
Signs and Symptoms
Bone Diseases, Developmental
Bone Diseases
Musculoskeletal Diseases
Bone Diseases, Endocrine
Pituitary Diseases
Hypothalamic Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Endocrine System Diseases
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs processed this record on May 22, 2017